Letters, Testimony & Comments

February 12, 2004
Testimony of the Biotechnology Industry Organization Submitted to the House Economic Development and Business Concerns Committee February 12, 2004 Regarding House Bill 2034:The Prohibition of Bioprospecting on Public Lands On behalf of the...
February 12, 2004
HB 2034 proposes a ban on bioprospecting on public lands (Feb. 12, 2004).
February 4, 2004
RE: Decision not to exempt transgenic ornamental fish from the resticted species list in Section 671, Title 14 California Code of Regulations Dear Mr. Flores: On behalf of BayBIO, BIOCOM and the Biotechnology Industry Organization (BIO), we...
February 4, 2004
Letter to California Fish and Game Commission: regarding a decision not to exempt transgenic ornamental fish from the restricted species list (Feb. 4, 2004).
February 2, 2004
Dear Sir/Madam: The following comments are provided by the Biotechnology Industry Organization (BIO). BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50...
February 2, 2004
February 2, 2004 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, Maryland 20852 Re: Docket No. 2003D-0497, Federal Register: November 4, 2003 (Volume 68, Number 213, Page 62461-62463) Dear...
December 22, 2003
On Providing Regulatory Submissions in Electronic Format - General Considerations.
December 12, 2003
December 5, 2003
CMC for Human Somatic Cell Therapy INDs
December 4, 2003
Comparability Protocols - Protein Drug Products and Biological Products - Chemistry, Manufacturing, and Controls Information.
November 19, 2003
The bill proposes a five year ban on open-air plantings of plant-made pharmaceuticals (Nov. 19, 2003).